US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist
  • 4.870
  • -0.160-3.18%
Close Apr 25 16:00 ET
704.29MMarket Cap-9018P/E (TTM)

About Aurinia Pharmaceuticals Company

Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Company Profile

SymbolAUPH
Company NameAurinia Pharmaceuticals
Listing DateFeb 25, 2000
Founded1993
CEOMr. Peter S. Greenleaf
MarketNASDAQ
Employees300
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address14315 – 118 Avenue,Suite 140
CityEdmonton
ProvinceAlberta
CountryCanada
Zip CodeT5L 4S6
Phone1-250-744-2487
Websitehttp://www.auriniapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Peter S. Greenleaf
  • President, Chief Executive Officer and Director
  • 1.24M
  • Scott Michael Habig
  • Chief Commercial Officer
  • --
  • Michael R. Martin
  • Chief Business Officer
  • --
  • Joseph M. Miller
  • Chief Financial Officer and Principal Accounting Officer
  • 710.03K
  • Stephen P. Robertson
  • Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
  • 722.40K
  • Matthew Donley
  • Executive Vice President, Operations and Strategy
  • 730.21K
  • Jeffrey Allen Bailey
  • Director
  • --
  • Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
  • Director
  • --
  • R. Hector Mackay-Dunn, J.D.,Q.C.
  • Independent Director
  • 259.38K
  • Dr. Brinda Balakrishnan, M.D.,PhD
  • Independent Director
  • 364.75K
  • Dr. David R.W. Jayne, F.R.C.P.,M.D.
  • Independent Director
  • 251.67K
  • Jill D. Leversage
  • Independent Director
  • 260.84K
  • Dr. Daniel G. Billen, PhD
  • Independent Director
  • 246.67K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg